CVS Health Corporation (CVS)

NASDAQHealthcare

$78.2
-$0.28 (-0.4%)
Market closed

February 17, 2026 at 21:00 UTC

Interactive Chart
CVS
1H
3H
6H
12H
1D
1W
1M
3M
6M
1Y
2Y
5Y
All

02:46:23 UTC

About CVS Health Corporation

Name

CVS Health Corporation

CEO

J. David Joyner

Industry

Healthcare

Year Founded

1963

Employees

219,000

CVS Health Corporation is an integrated health company that brings together retail pharmacies, pharmacy benefit management, and health insurance to serve patients, providers, and plan sponsors. Community locations fill prescriptions, offer vaccinations, and provide front-of-store health and wellness products. Behind the counter, clinical programs and digital tools support adherence and home delivery. The benefit management unit negotiates drug access and manages formularies for employers and government plans, while the insurance business coordinates networks, care management, and member services. Together these pieces link everyday pharmacy needs with broader coverage and care navigation. CVS Health operates across the United States and participates in the healthcare sector where access, affordability, and coordinated outcomes are central aims.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 6 Buy, 8 Hold, 7 Sell
Buy6
Hold8
Sell7
Fundamentals & Financials
Revenue (TTM)
$402B
Net Income (TTM)
$1.7B
EPS (TTM)
$1.41
ROA (TTM)
0.7%
Current Ratio
0.84
Dividend Yield
0.097%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement
ItemQ4 2025
Revenue$105,693M
Cost of Sales$92,126M
Gross Profit$13,567M
Operating Income$2,112M
Net Income$2,943M
EPS$2.32
Technical Indicators

CVS Health Corporation's Technical Indicators Summary

CVS’s technical profile presents a neutral outlook as momentum indicators like the RSI and MACD hover near equilibrium, reflecting a lack of strong directional bias. The price remains below short- and medium-term moving averages, which signal selling pressure, yet it is still above the longer-term 200-day averages that suggest underlying support. Trend strength is subdued, with the ADX indicating a weak trend, while volatility remains moderate as shown by the average true range. Meanwhile, the on-balance volume favors buying, hinting at some accumulation despite limited price conviction. Overall, CVS exhibits a balanced technical stance with no clear momentum or trend dominance at this time.

Buy
6 signals
Neutral
8 signals
Sell
7 signals
Overall: Neutral38% Neutral signals
IndicatorValue
RSI (14)
46.22
Stochastic %K (14, 3, 3)
45.15
CCI (20)
-1.11
WPR (14)
-86.81
Momentum (10)
-1.53
MFI
48.15
MACD Level (12, 26)
0.39
Bollinger Bands
$77.51 - $81.71
ATR (14)
$1.86 (2.37%)
ADX (14)
12.98
OBV
253,484,100
Simple Moving Averages
$71.56 - $80.21(5 indicators)
Exponential Moving Averages
$71.96 - $79.95(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

By the close, CVS continued to sit slightly below yesterday’s 78.48, with a small -0.344% gap down and a finish near 78.21. The session finished with CVS's options still showing an aggressive upside skew, put/call at 0.49. CVS remains slightly below yesterday's close amid mixed headlines about operational efficiency and market transition.

Price Change

from $78.48 close

-$0.27

Trading Volume

Below avg (9.4M)

4.1M

vs S&P 500 Today

Moderate Underperformance

-0.42%

52-Week Position

Upper range

74.1%

Updated: February 17, 2026 at 21:01 UTC

Quote Summary
OpenPrevious Close
$79.18$78.48
Day Range52 Week Range
$77.85 - $79.75$58.35 - $85.15
VolumeAvg. Volume
4.1M8.4M
Market CapP/E Ratio
$99.4B56.3